Cure51

Cure51 is a techbio company that identifies and collects clinical and multi-omics data from long-term cancer survivors across multiple continents to discover biological signatures and drug targets for oncology development. The company collaborates with leading cancer research centers to analyze exceptional cancer survivors' biology and develop precision medicine tools to inform novel cancer therapeutics.